Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis

Scandinavian Journal of Rheumatology

Volumn 29, Issue 4, 2000, Pages 232-235

  Kaipiainen Seppanen O ^a   Myllykangas Luosujarvi R ^a   Lampainen, E ^a   Ikaheimo R ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Rheumatoid arthritis; Secondary amyloidosis

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; CHLOROQUINE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE;

ADULT; AMYLOIDOSIS; ARTICLE; COMBINATION CHEMOTHERAPY; DIALYSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

AMYLOIDOSIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FINLAND; GLUCOCORTICOIDS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 0034543826     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097400750041370     Document Type: Article

References (15)

1. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement
2. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis
3. Increased mortality in rheumatoid arthritis
4. Ten year mortality and causes of death in patients with rheumatoid arthritis
5. Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis
6. Longterm mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well
7. Amyloidosis - Incidence and early risk factors in patients with rheumatoid arthritis
8. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland
9. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency
10. Amyloidosis in juvenile chronic arthritis: A morbidity and mortality study
11. Outcome of patients with secondary amyloidosis in dialysis treatment
12. Comparison of combination therapy with single drug therapy in early rheumatoid arthritis: A randomised trial
13. Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10-21 year followup of 16 patients with rheumatic discase treated with alkylating cytostatics
14. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died